A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
Active, not recruiting · NCT05848739 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm | Active, not recruiting | Phase 1 | 2026-07-22 | NCT05848739 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sapience Therapeutics | 3 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Duke Universtiy | Durham | United States | 1 |
| Fred Hutch Cancer Center | Seattle | United States | 12 |
| Ochsner Clinic Foundation | New Orleans | United States | 1 |
| OU Health Stephenson Cancer Center | Oklahoma City | United States | 23 |
| Sanford Cancer Center | Sioux Falls | United States | 12 |
| Sarah Cannon Research Institute - CO | Denver | United States | 1 |
| START Midwest | Grand Rapids | United States | 4 |
| University of Alabama | Birmingham | United States | 29 |
| Usc Norris Comprehensive Cancer Center | Los Angeles | United States | 67 |
| Westchester Medical Center | Valhalla | United States | 53 |